Back to top

J.P. Morgan Initiates a Hold Rating on BioCryst (BCRX)

BioCryst received a Hold rating and a $12.00 price target from J.P. Morgan analyst Jessica Fye today. According to TipRanks, Fye is a 5-star analys...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

BioCryst Pharmaceuticals, Inc. (BCRX)